Projects funded by the NCN


Information on the principal investigator and host institution

Information of the project and the call

Keywords

Equipment

Delete all

Changes in Candida albicans drug resistance and virulence in responce to different carbon sources

2016/23/B/NZ1/01928

Keywords:

Candida albicans ABC transporters ergosterol multidrug resistance

Descriptors:

  • NZ1_10: Microbiology
  • NZ1_3: Biophysics
  • NZ1_11: Other related subjects

Panel:

NZ1 - Molecular biology, structural biology, biotechnology: molecular biology, structural biology, biotechnology

Host institution :

Uniwersytet Wrocławski, Wydział Biotechnologii

woj. dolnośląskie

Other projects carried out by the institution 

Principal investigator (from the host institution):

dr hab. Anna Krasowska 

Number of co-investigators in the project: 6

Call: OPUS 12 - announced on 2016-09-15

Amount awarded: 1 059 200 PLN

Project start date (Y-m-d): 2017-07-12

Project end date (Y-m-d): 2021-07-11

Project duration:: 48 months (the same as in the proposal)

Project status: Project settled

Project description

Download the project description in a pdf file

Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.

Equipment purchased [PL]

  1. Tensjometr.
  2. Ultrawirówka (170 000 PLN)

Information in the final report

  • Publication in academic press/journals (7)
  1. Crucial role of ergosterol in plasma membrane composition, localisation and activity of Cdr1p and H+-ATPase in Candida albicans
    Authors:
    Suchodolski J., Muraszko J., Bernat P., Krasowska A.
    Academic press:
    Microorganisms (rok: 2019, tom: 22, strony: 378-413), Wydawca: MDPI
    Status:
    Published
    DOI:
    10.3390/microorganisms7100378 - link to the publication
  2. Plasma membrane potential of Candida albicans measured by di-4-ANEPPS fluorescence depends on growth phase and regulatory factors
    Authors:
    Suchodolski J. and Krasowska A.
    Academic press:
    Microorganisms (rok: 2019, tom: 7, strony: 110-137), Wydawca: MDPI
    Status:
    Published
    DOI:
    10.3390/microorganisms7040110 - link to the publication
  3. Capric acid secreted by Saccharomyces boulardii influences the susceptibility of Candida albicans to fluconazole and amphotericin B
    Authors:
    Suchodolski J., Derkacz D., Bernat P., Krasowska A.
    Academic press:
    Scientific Report (rok: 2021, tom: 11, strony: 6519-6527), Wydawca: Springer Nature Research
    Status:
    Published
    DOI:
    10.1038/s41598-021-86012-9 - link to the publication
  4. Fructose induces fluconazole resistance in Candida albicans through activation of Mdr1 and Cdr1 transporters
    Authors:
    Suchodolski J. and Krasowska A.
    Academic press:
    International Journal of Molecular Sciences (rok: 2021, tom: 22, strony: 2127-2136), Wydawca: MDPI
    Status:
    Published
    DOI:
    10.3390/ijms22042127 - link to the publication
  5. Lactate like fluconazole reduces ergosterol content in plasma membrane and synergically kills Candida albicans
    Authors:
    Suchodolski J., Muraszko J., Bernat P. and Krasowska A.
    Academic press:
    International Journal of Molecular Sciences (rok: 2021, tom: 22, strony: 5219-5228), Wydawca: MDPI
    Status:
    Published
    DOI:
    10.3390/ijms22105219 - link to the publication
  6. Lipid composition and cell surface hydrophobicity of Candida albicans influence the efficacy of fluconazole-gentamicin treatment
    Authors:
    Suchodolski J., Muraszko J., Korba A., Bernat P., Krasowska A.
    Academic press:
    Yeast (rok: 2020, tom: 37, strony: 117-129), Wydawca: Wiley
    Status:
    Published
    DOI:
    10.1002/yea.3455 - link to the publication
  7. Fluconazole and Lipopeptide Surfactin Interplay During Candida albicans Plasma Membrane and Cell Wall Remodeling Increases Fungal Immune System Exposure
    Authors:
    Jakub Suchodolski, Daria Derkacz, Jakub Muraszko, Jarosław J. Panek , Aneta Jezierska , Marcin Łukaszewicz and Anna Krasowska
    Academic press:
    Pharmaceutics (rok: 2020, tom: 12, strony: 314-336), Wydawca: MDPI
    Status:
    Published
    DOI:
    10.3390/pharmaceutics12040314 - link to the publication